|
Delayed
Canadian Securities Exchange
11:40:21 2026-09-08 EDT
|
5-day change | 1st Jan Change | ||
| 1.030 CAD | -4.63% |
|
-0.96% | -37.95% |
| 09-01 | Cresco Labs Inc. (CSE:CL) acquired PharmaCann Penn, LLC for $50 million. | CI |
| 08-06 | Cresco Labs Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- CL Stock
- Consensus Cresco Labs Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
